Zydus Lifesciences reports six USFDA observations at its Gujarat API unit, unrelated to Data Integrity, amid a stock price decline. The company is confident in timely resolution.
Laurus Labs' US subsidiary, Laurus Generics Inc, received a Form 483 with one observation from the USFDA following a detailed inspection. The company is committed to addressing the...
Aurobindo Pharma reports that the USFDA inspected its subsidiary Apitoria Pharma's API manufacturing facility in Hyderabad with two procedural observations, to be addressed within ...
